See more : Wildcat Petroleum Plc (WCAT.L) Income Statement Analysis – Financial Results
Complete financial analysis of Biovica International AB (publ) (BIOVIC-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biovica International AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- The Standard Batteries Limited (STDBAT.BO) Income Statement Analysis – Financial Results
- Old Mutual Limited (OMU.JO) Income Statement Analysis – Financial Results
- Labrador Uranium Inc. (LURAF) Income Statement Analysis – Financial Results
- Tachibana Eletech Co., Ltd. (8159.T) Income Statement Analysis – Financial Results
- Arrowhead Pharmaceuticals, Inc. (0HI3.L) Income Statement Analysis – Financial Results
Biovica International AB (publ) (BIOVIC-B.ST)
About Biovica International AB (publ)
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.29M | 3.38M | 2.05M | 2.08M | 1.67M | 3.01M | 2.72M | 632.00K | 2.43M | 459.00K | 4.05M |
| Cost of Revenue | 413.00K | -1.23M | -2.62M | -3.19M | -6.82M | -5.63M | -5.58M | -4.46M | -4.37M | -3.67M | 441.54K |
| Gross Profit | 6.88M | 4.62M | 4.67M | 5.27M | 8.49M | 8.64M | 8.30M | 5.09M | 6.80M | 4.13M | 3.60M |
| Gross Profit Ratio | 94.33% | 136.44% | 228.17% | 253.73% | 507.84% | 287.42% | 304.92% | 805.70% | 279.69% | 898.69% | 89.08% |
| Research & Development | 5.09M | 5.35M | 13.00M | 7.58M | 2.62M | 1.45M | 1.30M | 1.30M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 15.33M | 15.39M | 11.96M | 9.50M | 9.67M | 8.34M | 7.10M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 128.63M | 106.69M | 59.35M | 15.33M | 15.39M | 11.96M | 9.50M | 9.67M | 8.34M | 7.10M | 8.07M |
| Other Expenses | 5.12M | 0.00 | 0.00 | 30.35M | 22.92M | 18.66M | 16.77M | 10.86M | 2.28M | 728.00K | 0.00 |
| Operating Expenses | 133.73M | 115.54M | 65.97M | 45.68M | 38.30M | 30.62M | 26.27M | 20.53M | 13.68M | 11.35M | 8.19M |
| Cost & Expenses | 134.14M | 114.31M | 63.34M | 42.49M | 31.49M | 24.99M | 20.69M | 16.07M | 9.31M | 7.69M | 8.63M |
| Interest Income | 1.16M | 271.00K | 188.00K | 855.00K | 443.00K | 229.00K | 0.00 | 1.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 289.00K | 10.00K | 79.00K | 60.00K | 443.00K | 35.00K | 54.00K | 9.00K | 182.00K | 545.00K | 788.24K |
| Depreciation & Amortization | 9.43M | 4.44M | 6.44M | 2.76M | 4.17M | 3.02M | 2.74M | 1.82M | 1.61M | 1.32M | 584.63K |
| EBITDA | -119.51M | -105.96M | -53.47M | -36.56M | -25.65M | -18.50M | -15.22M | -13.02M | -4.17M | -5.18M | -4.00M |
| EBITDA Ratio | -1,639.31% | -3,030.41% | -2,670.17% | -1,597.69% | -1,534.77% | -622.10% | -558.87% | -2,060.60% | -133.02% | -1,128.32% | -98.86% |
| Operating Income | -126.85M | -110.46M | -60.10M | -40.18M | -29.82M | -21.72M | -17.96M | -14.84M | -4.60M | -6.50M | -4.58M |
| Operating Income Ratio | -1,739.99% | -3,264.10% | -2,938.92% | -1,934.57% | -1,784.32% | -722.73% | -659.42% | -2,347.94% | -189.10% | -1,415.69% | -113.31% |
| Total Other Income/Expenses | 2.71M | -222.00K | 110.00K | 795.00K | -443.00K | 194.00K | -54.00K | -158.00K | -432.00K | -545.04K | -788.24K |
| Income Before Tax | -124.14M | -110.68M | -59.99M | -39.39M | -30.26M | -21.52M | -18.01M | -14.85M | -5.03M | -7.04M | -5.37M |
| Income Before Tax Ratio | -1,702.83% | -3,270.69% | -2,933.55% | -1,896.29% | -1,810.83% | -716.27% | -661.40% | -2,349.37% | -206.87% | -1,534.42% | -132.80% |
| Income Tax Expense | 687.00K | -187.00K | 12.00K | 96.00K | 59.00K | 32.00K | 54.00K | 9.00K | -1.85M | 545.00K | 0.00 |
| Net Income | -124.82M | -110.49M | -60.00M | -39.48M | -30.32M | -21.56M | -18.06M | -14.86M | -5.03M | -7.04M | -5.37M |
| Net Income Ratio | -1,712.25% | -3,265.13% | -2,934.13% | -1,900.96% | -1,814.36% | -717.34% | -663.39% | -2,350.79% | -206.87% | -1,534.42% | -132.80% |
| EPS | -2.14 | -2.98 | -1.96 | -1.29 | -1.20 | -1.14 | -1.02 | -0.84 | -0.28 | -0.40 | -0.30 |
| EPS Diluted | -2.14 | -2.98 | -1.96 | -1.29 | -1.20 | -1.14 | -0.99 | -0.82 | -0.28 | -0.40 | -0.30 |
| Weighted Avg Shares Out | 58.41M | 37.05M | 30.59M | 30.55M | 25.34M | 18.89M | 17.76M | 17.76M | 17.76M | 17.76M | 17.76M |
| Weighted Avg Shares Out (Dil) | 58.41M | 37.05M | 30.59M | 30.55M | 25.34M | 18.89M | 18.16M | 18.16M | 17.76M | 17.76M | 17.76M |
Source: https://incomestatements.info
Category: Stock Reports